Electromed, Inc.

AMEX:ELMD

Medical - Devices

Healthcare
$23.40 +1.16%

+$0.43 today

Market cap
$191.27M
Beta
0.52
P/E (TTM)
30.5
EPS (TTM)
$1.23
52W Low $17.73High $40.00

Volume 0.05M

Average 0.06M

ELMD EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Electromed, Inc.AMEX: ELMD

EBITDA · Q3 FY2026 · quarter ended Mar 2026

EBITDA growth accelerates

Q3 FY2026 EBITDA of $4.15M rose 61.9% year over year, ahead of the +39.5% change in trailing-twelve-month EBITDA. Sequentially, it rose 4.2% from the prior quarter. Over 3 fiscal years it compounded at +46.7% a year.

Context

  • EBITDA amounted to 17.9% of revenue in FY2025, up 3.5 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 2 analysts of $15M (+30.9%) for the fiscal year ending Jun 2026, a slowdown from the +45.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.15M+4.2% QoQ
Last fiscal yearJun 2025
$11.46M+45.4% YoY
LTMMar 2026
$14.78M+39.5% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+61.9%+9.9%-52.0 pp
1 year+45.4%+30.9%-14.5 pp
3-year CAGR+46.7%+23.3%-23.4 pp
5-year CAGR+5.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
11.46M USD
Year-over-year change
+45.4%
4-year CAGR
+32.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How ELMD compares with its peers on the latest reported figures

  • ELMD's LTM Mar 2026 EBITDA of $14.78M is the 5th highest of the 6 companies compared; the peer median is $53.03M.
  • Its year-over-year change of +39.5% is the highest of 6, against a peer median of +12.7%.
  • EBITDA amounts to 20.6% of revenue for ELMD, versus a peer median of 18.5%.
ELMD Competitors Peer median
EBITDA for ELMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RMDResMed Inc.LTM Jun 2026$2.17B +12.7%+16.5%38.3%
AHCOAdaptHealth Corp.LTM Apr 2026$462.48M -25.4%-7.2%16.2%
VMDViemed Healthcare, Inc.LTM Mar 2026$53.03M +28.1%+27.6%18.5%
TCMDTactile Systems Technology, Inc.LTM Mar 2026$41.52M +25.9%+181.6%12.1%
ELMDElectromed, Inc.LTM Mar 2026$14.78M +39.5%+46.7%20.6%
LUNGPulmonx CorporationLTM Mar 2026-$48.22M +9.4%—54.5%
Peer median (excluding ELMD) $53.03M+12.7%+22.1%18.5%

Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue35.76M41.66M48.07M54.72M64M
Cost of Revenue8.45M10.22M11.55M12.99M14.03M
Gross Profit27.31M31.44M36.52M41.73M49.97M
Gross Margin76.4%75.5%76.0%76.3%78.1%
Research & Development1.72M1.36M916K656K996K
Selling, General & Admin22.44M27.11M31.6M34.49M39.1M
Operating Expenses24.17M28.47M32.51M35.15M40.1M
Depreciation & Amortization610K628K613K841K1.17M
EBITDA3.78M3.63M4.7M7.88M11.46M
EBITDA Margin10.6%8.7%9.8%14.4%17.9%
Operating Income3.14M2.97M4.01M6.58M9.87M
Operating Margin8.8%7.1%8.3%12.0%15.4%
Interest Income39K25K78K455K624K
Interest Expense00000
Other Income / Expenses27K25K78K455K412K
Income Before Tax3.17M3M4.09M7.04M10.28M
Pre-Tax Margin8.9%7.2%8.5%12.9%16.1%
Income Tax Expense805K692K920K1.89M2.75M
Net Income2.36M2.31M3.17M5.15M7.54M
Net Margin6.6%5.5%6.6%9.4%11.8%
EPS (Basic)0.280.270.370.600.90
EPS (Diluted)0.270.260.360.580.86
Weighted Avg Shares8.57M8.47M8.46M8.56M8.33M
Weighted Avg Shares (Diluted)8.91M8.77M8.7M8.86M8.72M

Electromed, Inc.

AMEX:ELMD

Intrinsic Alpha fair value

Locked

Current Price

$23.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.